
Cardiovascular Systems CSII
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Cardiovascular Systems Gesamtverbindlichkeiten 2011-2026 | CSII
Gesamtverbindlichkeiten Jährlich Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 73.2 M | 81.6 M | 70.7 M | 70.6 M | 68.9 M | 75.6 M | 41.5 M | 31.9 M | 29.8 M | 30.1 M | 30.9 M | 25.1 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 81.6 M | 25.1 M | 52.5 M |
Gesamtverbindlichkeiten Vierteljährlich Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72.1 M | 69.9 M | 73.2 M | 70.5 M | 66.9 M | 69.1 M | 81.6 M | 81.6 M | 75.1 M | 73.3 M | 70.7 M | 76.9 M | 80.9 M | 75 M | 70.6 M | 70.6 M | 68.6 M | 66.3 M | 68.9 M | 68.9 M | 66.1 M | 70.3 M | 75.6 M | 75.6 M | 46.6 M | 35.4 M | 41.5 M | 41.5 M | 30 M | 31.8 M | 31.9 M | 31.9 M | 32.5 M | 33.9 M | 29.8 M | 29.8 M | 24.9 M | 29.8 M | 30.1 M | 30.1 M | 27.5 M | 31.1 M | 30.9 M | 30.9 M | 30.1 M | 25 M | 25.1 M | 25.1 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 81.6 M | 24.9 M | 52 M |
Gesamtverbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
2.24 M | $ 2.23 | 0.52 % | $ 3.48 M | ||
|
Acutus Medical
AFIB
|
54.8 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
AdaptHealth Corp.
AHCO
|
2.79 B | $ 10.41 | -0.41 % | $ 1.41 B | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 9.43 | -15.49 % | $ 267 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Alphatec Holdings
ATEC
|
126 M | $ 13.01 | -0.34 % | $ 1.95 B | ||
|
Cytosorbents Corporation
CTSO
|
36.3 M | $ 0.66 | -3.69 % | $ 35.9 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.05 | 0.02 % | $ 151 M | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
Cognyte Software Ltd.
CGNT
|
281 M | $ 8.28 | -0.96 % | $ 594 M | ||
|
Establishment Labs Holdings
ESTA
|
334 M | $ 64.65 | -0.55 % | $ 1.91 B | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
87.2 M | $ 4.16 | -2.58 % | $ 881 M | ||
|
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Boston Scientific Corporation
BSX
|
16.7 B | $ 70.72 | -0.67 % | $ 105 B | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
CONMED Corporation
CNMD
|
1.29 B | $ 37.25 | -0.24 % | $ 1.16 B | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | ||
|
InMode Ltd.
INMD
|
83.2 M | $ 13.55 | -0.73 % | $ 876 M | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Axonics Modulation Technologies
AXNX
|
89.2 M | - | - | $ 3.31 B | ||
|
IRIDEX Corporation
IRIX
|
24.9 M | $ 1.33 | - | $ 21.5 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
OrthoPediatrics Corp.
KIDS
|
162 M | $ 16.91 | -1.77 % | $ 397 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
53.1 M | $ 18.43 | -0.11 % | $ 121 M | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
Abbott Laboratories
ABT
|
36.6 B | $ 109.71 | -0.9 % | $ 191 B | ||
|
Delcath Systems
DCTH
|
12.4 M | $ 9.59 | -1.54 % | $ 344 M | ||
|
Bio-Rad Laboratories
BIO
|
2.79 B | $ 268.09 | -0.52 % | $ 7.56 B | ||
|
Helius Medical Technologies
HSDT
|
5.34 M | $ 2.1 | -3.46 % | $ 1.28 M | ||
|
AxoGen
AXGN
|
92.8 M | $ 32.26 | -1.51 % | $ 1.49 B | ||
|
Align Technology
ALGN
|
2.36 B | $ 172.39 | -2.12 % | $ 12.9 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
2.49 B | $ 8.78 | -3.52 % | $ 676 M | ||
|
Bruker Corporation
BRKR
|
3.99 B | $ 33.42 | -0.95 % | $ 4.98 K | ||
|
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
52 M | $ 3.9 | 4.28 % | $ 160 M | ||
|
Second Sight Medical Products
EYES
|
24 M | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
389 M | $ 0.37 | -4.45 % | $ 38 M | ||
|
IRadimed Corporation
IRMD
|
14.2 M | $ 103.06 | 0.25 % | $ 1.31 B |